WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2001085729) NOVEL VITRONECTIN RECEPTOR ANTAGONISTS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2001/085729    International Application No.:    PCT/FR2001/001357
Publication Date: 15.11.2001 International Filing Date: 04.05.2001
Chapter 2 Demand Filed:    17.11.2001    
IPC:
C07D 403/12 (2006.01), C07D 413/12 (2006.01), C07D 417/12 (2006.01), C07D 471/04 (2006.01), C07D 498/04 (2006.01)
Applicants: AVENTIS PHARMA S.A. [FR/FR]; 20, avenue Raymond Aron F-92160 Antony (FR) (For All Designated States Except US).
DEMASSEY, Jacques [FR/FR]; (FR) (For US Only).
GOURVEST, Jean-François [FR/FR]; (FR) (For US Only).
RUXER, Jean-Marie [FR/FR]; (FR) (For US Only).
WESTON, John, Bernard [GB/FR]; (FR) (For US Only).
LEFRANCOIS, Jean-Michel [FR/FR]; (FR) (For US Only)
Inventors: DEMASSEY, Jacques; (FR).
GOURVEST, Jean-François; (FR).
RUXER, Jean-Marie; (FR).
WESTON, John, Bernard; (FR).
LEFRANCOIS, Jean-Michel; (FR)
Agent: ROUSSEAU, Pierrick; Aventis Pharma S.A. 102, route de Noisy F-93235 Romainville Cedex (FR)
Priority Data:
00/05859 09.05.2000 FR
Title (EN) NOVEL VITRONECTIN RECEPTOR ANTAGONISTS
(FR) NOUVEAUX DERIVES ANTAGONISTES DU RECEPTEUR DE LA VITRONECTINE
Abstract: front page image
(EN)The invention concerns vitronectin receptor antagonist compounds of formula (I): R¿1?-Y-A-B-D-E-F-G wherein R¿1?, Y, A, B, D, E, F, and G are as defined in the description, their physiologically acceptable salts and their prodrugs, methods for preparing compounds of formula (I), their use, in particular as medicine and pharmaceutical compositions containing them.
(FR)L'invention a pour objet des composés antagonistes du récepteur de la vitronectine de formule (I): R¿1?-Y-A-B-D-E-F-G dans laquelle R¿1?, Y, A, B, D, E, F, et G ont les significations indiquées dans la description, leurs sels physiologiquement acceptables et leurs prodrugs, leurs procédés de préparation des composés de formule (I), leur application, en particulier à titre de médicament et les compositions pharmaceutiques les renfermant.
Designated States: AE, AG, AL, AU, BA, BB, BG, BR, BZ, CA, CN, CO, CR, CU, CZ, DM, DZ, EE, GD, GE, HR, HU, ID, IL, IN, IS, JP, KP, KR, LC, LK, LR, LT, LV, MA, MG, MK, MN, MX, NO, NZ, PL, RO, SG, SI, SK, TT, UA, US, UZ, VN, YU, ZA.
African Regional Intellectual Property Organization (GH, GM, KE, LS, MW, MZ, SD, SL, SZ, TZ, UG, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LU, MC, NL, PT, SE, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GW, ML, MR, NE, SN, TD, TG).
Publication Language: French (FR)
Filing Language: French (FR)